Marijuana for PTSD: Participant Screening Begins in Phoenix, Arizona

On October 3, 2016, researchers at the Phoenix, Ariz., site of our upcoming trial of smoked marijuana for symptoms of PTSD in U.S. veterans began screening participants. On September 29, the Phoenix site received the final delivery of study supplies, including the pipes that participants will use for self-administering marijuana. Former Clinical Research Associate Ben Shechet of MAPS Public Benefit Corporation (MPBC) has transitioned his role to become the new Study Coordinator for our study site in Phoenix.